SG11202103027UA - Glycated hemoglobin (%) assay method - Google Patents

Glycated hemoglobin (%) assay method

Info

Publication number
SG11202103027UA
SG11202103027UA SG11202103027UA SG11202103027UA SG11202103027UA SG 11202103027U A SG11202103027U A SG 11202103027UA SG 11202103027U A SG11202103027U A SG 11202103027UA SG 11202103027U A SG11202103027U A SG 11202103027UA SG 11202103027U A SG11202103027U A SG 11202103027UA
Authority
SG
Singapore
Prior art keywords
assay method
glycated hemoglobin
glycated
hemoglobin
assay
Prior art date
Application number
SG11202103027UA
Other languages
English (en)
Inventor
Mieko Ota
Osamu Miyazaki
Satoko SEO
Mitsuaki Yamamoto
Tomohisa Nishio
Original Assignee
Sekisui Medical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd filed Critical Sekisui Medical Co Ltd
Publication of SG11202103027UA publication Critical patent/SG11202103027UA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G01N33/723—Glycosylated haemoglobin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG11202103027UA 2018-09-28 2019-09-27 Glycated hemoglobin (%) assay method SG11202103027UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018184017 2018-09-28
PCT/JP2019/038076 WO2020067396A1 (ja) 2018-09-28 2019-09-27 糖化ヘモグロビン（％）の測定方法

Publications (1)

Publication Number Publication Date
SG11202103027UA true SG11202103027UA (en) 2021-04-29

Family

ID=69950627

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103027UA SG11202103027UA (en) 2018-09-28 2019-09-27 Glycated hemoglobin (%) assay method

Country Status (8)

Country Link
US (1) US20210389306A1 (ko)
EP (1) EP3859332B1 (ko)
JP (1) JP7382071B2 (ko)
KR (1) KR20210068048A (ko)
CN (1) CN112740037A (ko)
SG (1) SG11202103027UA (ko)
TW (1) TW202020453A (ko)
WO (1) WO2020067396A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4328318A1 (en) * 2021-04-19 2024-02-28 Osaka University Method for characterizing molecule delivery particles
CN116046506B (zh) * 2022-07-26 2023-11-10 南京立顶医疗科技有限公司 天然高纯度糖化血红蛋白HbA1c和血红蛋白HbA0的分离纯化方法
CN115951072B (zh) * 2022-12-06 2024-05-14 北京鸿宇泰生物科技有限公司 一种糖化血红蛋白-c肽联合检测试剂盒

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU529210B3 (en) * 1983-02-02 1983-04-14 Australian Monoclonal Development Pty. Ltd. Monoclonal antibody in occult blood diagnosis
CA1339952C (en) 1984-10-29 1998-07-14 William J. Knowles Immunoassays for denatured protein analytes, particularly hb alc, and monoclonal antibodies thereto
JP2596321B2 (ja) 1992-06-16 1997-04-02 富士レビオ株式会社 糖化ヘモグロビンの測定方法
JPH06167495A (ja) 1992-07-14 1994-06-14 S R L:Kk 凝集イムノアッセイ法
JP2677753B2 (ja) * 1993-07-22 1997-11-17 株式会社エスアールエル 凝集イムノアッセイ法
JPH0954088A (ja) * 1995-08-11 1997-02-25 Kdk Corp 微量ヘモグロビン▲Ａ１ｃ▼測定用乾式試験具
JPH1010127A (ja) * 1996-06-25 1998-01-16 Sekisui Chem Co Ltd 凝集イムノアッセイ法
JP4733335B2 (ja) * 2000-08-29 2011-07-27 協和メデックス株式会社 再現性良好な凝集イムノアッセイ法及び試薬
WO2002088185A2 (en) * 2001-04-26 2002-11-07 Dakocytomation Denmark A/S Pan-specific monoclonal antibody
ES2268015T3 (es) 2001-05-18 2007-03-16 Srl, Inc. Procedimiento de inmunoensayo.
JP2002365290A (ja) 2001-06-06 2002-12-18 Internatl Reagents Corp 糖化ヘモグロビンの測定方法
KR20060023098A (ko) * 2004-09-08 2006-03-13 주식회사 바이오포커스 당화헤모글로빈에 대해 특이성을 갖는 단일클론항체 개발및 정제방법
NL1033365C2 (nl) * 2007-02-09 2008-08-12 Medavinci Dev B V Inrichting en werkwijze voor scheiden en analyseren van bloed.
JP5465008B2 (ja) 2007-10-30 2014-04-09 パナソニック株式会社 ヘモグロビン及びヘモグロビン誘導体の測定方法、測定キット
US8715942B2 (en) 2007-11-20 2014-05-06 Siemens Healthcare Diagnostics Inc. Methods for the detection of glycated hemoglobin
CN102405412B (zh) * 2008-07-04 2015-01-14 积水医疗株式会社 免疫学测定的灵敏度增强方法或避免血红蛋白影响的方法
US9341633B2 (en) * 2008-12-11 2016-05-17 Sekisui Medical Co., Ltd. Method for pre-treating sample containing glycated hemoglobin
US8603828B2 (en) 2009-11-18 2013-12-10 Bio-Rad Laboratories, Inc. Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms
WO2014112318A1 (ja) 2013-01-16 2014-07-24 富士レビオ株式会社 検体中のヘモグロビンA1cの免疫測定方法
JP2016031250A (ja) * 2014-07-25 2016-03-07 株式会社堀場製作所 標的タンパク質の測定試薬および該試薬を用いた測定方法
CN105137082A (zh) * 2015-07-31 2015-12-09 柏荣诊断产品（上海）有限公司 一种双试剂糖化血红蛋白检测试剂盒
JP6740083B2 (ja) * 2015-10-23 2020-08-12 株式会社Ｌｓｉメディエンス 免疫学的測定試薬、測定方法及び測定範囲の拡大方法
WO2017139478A1 (en) * 2016-02-09 2017-08-17 Biomedomics, Inc. Devices systems and methods for quantifying hemoglobin s concentration
CN107219372A (zh) * 2017-05-31 2017-09-29 吉林省汇酉生物技术股份有限公司 一种糖化血红蛋白的检测试剂及方法
CN108414767B (zh) * 2018-01-31 2021-03-16 迈克生物股份有限公司 糖化血红蛋白测定试剂盒

Also Published As

Publication number Publication date
KR20210068048A (ko) 2021-06-08
JPWO2020067396A1 (ja) 2021-09-16
CN112740037A (zh) 2021-04-30
EP3859332B1 (en) 2023-08-23
US20210389306A1 (en) 2021-12-16
TW202020453A (zh) 2020-06-01
EP3859332A1 (en) 2021-08-04
EP3859332A4 (en) 2022-07-13
WO2020067396A1 (ja) 2020-04-02
JP7382071B2 (ja) 2023-11-16

Similar Documents

Publication Publication Date Title
IL288613A (en) Multispecific proteins
EP3773236A4 (en) HEMOGLOBIN AND REAGENTS STABILIZATION PROCESS FOR ITS IMPLEMENTATION
IL284664A (en) Multispecific binding proteins
SG11202107834YA (en) Out-of-order processing
EP3492600C0 (en) METHOD FOR MEASURING GLYCOLATED HEMOGLOBIN
SG11202103027UA (en) Glycated hemoglobin (%) assay method
DK3737402T3 (en) Modificeret protein
EP3403128A4 (en) SIMULTANEOUSLY SCANNING SCATTERING DURING SAMPLE PROCESSING
EP3517966A4 (en) REAGENT COMPOSITION FOR MEASURING GLYCATED HEMOGLOBIN AND METHOD FOR MEASURING GLYCED HEMOGLOBIN USING THE SAME
EP3120147A4 (en) Glycated protein assay
EP4003169A4 (en) MEASUREMENT OF GLYCOSYLATED HEMOGLOBIN
EP3537156A4 (en) METHOD FOR MEASURING THE RATIO OF GLYCATED HEMOGLOBIN
EP3783359A4 (en) PROCEDURE FOR HEMOGLOBIN ANALYSIS
IL284317A (en) FAB pseudoproteins are multispecific binding proteins
ZA202003722B (en) Modified globin proteins
SG11202102265UA (en) Hemoglobin assay reagent, assay kit and assay method
EP3838145A4 (en) OXIMETER
EP3903725A4 (en) CONNECTION STRUCTURE FOR PROCESSING
SG11202006140TA (en) Process for providing pegylated protein composition
GB201815670D0 (en) Protein editing
EP4076343C0 (en) RETINOL BASED SERUM
EP3838146A4 (en) OXIMETER
EP3677681A4 (en) GLYCULATED HEMOGLOBIN OXIDASE VARIANT AND MEASUREMENT METHOD
EP3636767A4 (en) PROCESS FOR MEASURING GLYCULATED HEMOGLOBIN
GB2585410B (en) Analysis